Skip to main content

Table 2 Recurrence, complications and postoperative mortality outcomes

From: Indications and outcomes of enterovesical and colovesical fistulas: systematic review of the literature and meta-analysis of prevalence

Author Median follow-up (months) Recurrence rate (%) Complication rate (%) Complications (description) Postoperative mortality (%)  
Pollard 195 (mean) 0 6.5 Cardiorespiratory complications 3.2; anastomotic leak 3.2% 3.2  
McNamara 106 (mean) 3.3 8.2 Urine leak 3.2%; enterocutaneous fistula 1.6%; wound infection 1.6% 1.6  
Holmes 13 18.2 45.5 Deep vein thrombosis 9.1%; chest infection 27.3%; pelvic abscess 9.1% 9.1  
McBeath 15.3 (mean) 2.8 18.6 Anastomotic leak 5.7%; small bowel obstruction 2.8%; ileus 1.4%; other 8.7% NR  
Munoz 34 9.1 42 NR 6  
Vasilevsky 30.8 0 40 Urinary tract infection 9.5%; atelectasis 7.1%; prolonged ileus 4.8%; arrhythmias 4.8%; other 13.8% 0  
Yamamoto 159 10 10 Anastomotic leak 6.7%; intrabdominal abscess 3.3% 0  
Walker 35 0 15.7 Urinary leak 5.3%; wound infection 5.2%; ischemic colitis 5.2% 5.2  
Menenakos 61.7 5.5 27.7 Anastomotic leak 6.6%; gastroparesis 6.6%; abdominal wall hematoma 6.6%; minor hemorrhage through the drain 6.6% 0  
Najjar 2–108 (range) 8.3 NR NR 0  
Kavanagh 6 (mean) 4 24 Acute renal failure 4%; acute pulmonary oedema 4%; atrial fibrillation 4%; incisional hernia 4%; wound infection 4%; anastomotic leak 4% 16  
Laurent 64 (mean) 0 18.2 Pulmonary infection 9.1%; postoperative hemorrhage 9.1% 0  
Ferguson 6.5 0 NR NR NR  
Melchior 68 0 8.2 Pneumonia 6.1%; wound infection 2% 0  
Lynn 31 11.1 NR NR 0  
Niebling 129 0 29 Wound infection 12.9%; urinary tract infection 6.5%; abscess formation 6.5%; anastomotic leak 3.1% 3.2  
Maciel 8.8 (mean) 1.3 29.3 Colocutaneous fistula 2.6%; 0  
Salgado-Nesme 18.6 (mean) 0    0  
Taxonera 101 1.3 13.9 Abdominal abscesses 6.3%; anastomotic leaks 2.5%; intestinal obstruction 1.3%; hemorrhage 3.8 NR  
Badic 12 0 43 NR 7  
El-Haddad 21 7.5 32.5 Anastomotic leak 7.5%; parastomal hernia 5%; colostomy retraction 2.5%; ileus 7.5% 7.5  
Nevo 49 0 18 Surgical site infection 6%; intra-abdominal abscess 6%; persistent postoperative fever 6% 0  
  1. NR not reported